{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:24:46Z","timestamp":1793838286431,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guizhou Provincial Basic Research Program","award":["ZK[2022] General 494"],"award-info":[{"award-number":["ZK[2022] General 494"]}]},{"name":"Science and Technology Foundation of Health Commission of Guizhou Province","award":["gzwjkj2020-1-185"],"award-info":[{"award-number":["gzwjkj2020-1-185"]}]},{"name":"research project in the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine","award":["GZEYK[2020]6"],"award-info":[{"award-number":["GZEYK[2020]6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gout is the most common inflammatory arthritis and closely related to metabolic syndrome, leading to excruciating pain and the decline in quality of patients\u2019 life. However, the pathogenesis of gout is still unclear, and novel biomarkers are demanded for the early prediction and diagnosis of gout.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed at profiling the dysregulated metabolic pathways in asymptomatic hyperuricemia (AHU) and gout and elucidating the associations between AHU, gout and metabolomics, which may aid in performing gout screening.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 300 participants, including 114 healthy controls, 92 patients with AHU, and 94 patients with gout, were analyzed by using a combination of dried blood spot (DBS) sampling and mass spectrometry (MS) technology. Multiple algorithms were applied to characterize altered metabolic profiles in AHU and gout. The mainly altered metabolites were identified by random forest analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were significant differences in AHU and gout compared with control group. The altered metabolites were involved in oxidation of fatty acids, carnitine synthesis, urea cycle, and amino acid metabolism in AHU and gout. Random forest classification of 16 metabolites yielded 3 important features to distinguish gout from AHU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Distinct metabolomic signatures were observed in AHU and gout. The selected metabolites may have the potential to improve the early detection of gout.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13018-023-04240-3","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:02:44Z","timestamp":1697014964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology"],"prefix":"10.1186","volume":"18","author":[{"given":"Shanshan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"issue":"1","key":"4240_CR1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12891-019-2519-y","volume":"20","author":"P Towiwat","year":"2019","unstructured":"Towiwat P, Chhana A, Dalbeth N. The anatomical pathology of gout: a systematic literature review. BMC Musculoskelet Disord. 2019;20(1):140.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"4240_CR2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4240_CR3","first-page":"892","volume":"55","author":"Z Xiaofeng","year":"2017","unstructured":"Xiaofeng Z, Yaolong C. 2016 China guidelines for management of gout. Chin J Intern Med. 2017;55(11):892\u20139.","journal-title":"Chin J Intern Med"},{"issue":"9","key":"4240_CR4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/annrheumdis-2014-205304","volume":"73","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, Stamp L. Hyperuricaemia and gout: time for a new staging system? Ann Rheum Dis. 2014;73(9):1598\u2013600.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4240_CR5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, House ME, Aati O, Tan P, Franklin C, Horne A, et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann Rheum Dis. 2015;74(5):908\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4240_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/biom11020280","volume":"11","author":"WZ Zhang","year":"2021","unstructured":"Zhang WZ. Why does hyperuricemia not necessarily induce gout? Biomolecules. 2021;11(2):280.","journal-title":"Biomolecules"},{"issue":"3","key":"4240_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11906-013-0344-5","volume":"15","author":"Z Soltani","year":"2013","unstructured":"Soltani Z, Rasheed K, Kapusta DR, Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep. 2013;15(3):175\u201381.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"4240_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","volume":"20","author":"JG Puig","year":"2008","unstructured":"Puig JG, Mart\u00ednez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 2008;20(2):187\u201391.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"4240_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.","journal-title":"BMC Med"},{"issue":"4","key":"4240_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","volume":"79","author":"M Souto-Carneiro","year":"2020","unstructured":"Souto-Carneiro M, T\u00f3th L, Behnisch R, Urbach K, Klika KD, Carvalho RA, et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis. 2020;79(4):499\u2013506.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4240_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.41479","volume":"73","author":"VM Holers","year":"2021","unstructured":"Holers VM. Challenges and opportunities: using omics to generate testable insights into pathogenic mechanisms in preclinical seropositive rheumatoid arthritis. Arthritis Rheumatol. 2021;73(1):1\u20134.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4240_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbcan.2018.04.009","volume":"1870","author":"AK Kaushik","year":"2018","unstructured":"Kaushik AK, DeBerardinis RJ. Applications of metabolomics to study cancer metabolism. Biochim Biophys Acta Rev Cancer. 2018;1870(1):2\u201314.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"4240_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/0973-1482.175428","volume":"14","author":"M Simonian","year":"2018","unstructured":"Simonian M, Mosallayi M, Mirzaei H. Circulating miR-21 as novel biomarker in gastric cancer: diagnostic and prognostic biomarker. J Cancer Res Ther. 2018;14(2):475.","journal-title":"J Cancer Res Ther"},{"key":"4240_CR14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpba.2014.12.017","volume":"113","author":"R Bujak","year":"2015","unstructured":"Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal. 2015;113:108\u201320.","journal-title":"J Pharm Biomed Anal"},{"key":"4240_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/23808993.2020.1724509","volume":"5","author":"V Chandran","year":"2020","unstructured":"Chandran V, Rahman P. Predicting therapeutic response through biomarker analysis in psoriatic arthritis, an example of precision medicine. Expert Rev Precis Med Drug Dev. 2020;5:35\u201342.","journal-title":"Expert Rev Precis Med Drug Dev"},{"issue":"1","key":"4240_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11306-013-0565-2","volume":"10","author":"E Albrecht","year":"2014","unstructured":"Albrecht E, Waldenberger M, Krumsiek J, Evans AM, Jeratsch U, Breier M, et al. Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabolomics. 2014;10(1):141\u201351.","journal-title":"Metabolomics"},{"issue":"1","key":"4240_CR17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13018-023-03585-z","volume":"18","author":"W Wang","year":"2023","unstructured":"Wang W, Kou J, Zhang M, Wang T, Li W, Wang Y, et al. A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis. J Orthop Surg Res. 2023;18(1):96.","journal-title":"J Orthop Surg Res"},{"issue":"9","key":"4240_CR18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.41733","volume":"73","author":"X Shen","year":"2021","unstructured":"Shen X, Wang C, Liang N, Liu Z, Li X, Zhu ZJ, et al. Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout. Arthritis Rheumatol. 2021;73(9):1738\u201348.","journal-title":"Arthritis Rheumatol"},{"key":"4240_CR19","volume":"230","author":"X Guo","year":"2023","unstructured":"Guo X, Zhou L, Wang Y, Suo F, Wang C, Zhou W, et al. Development of a fast and robust liquid chromatography-mass spectrometry-based metabolomics analysis method for neonatal dried blood spots. J Pharm Biomed Anal. 2023;230:115383.","journal-title":"J Pharm Biomed Anal"},{"issue":"33","key":"4240_CR20","doi-asserted-by":"crossref","first-page":"19621","DOI":"10.1039\/C9RA10684G","volume":"10","author":"G Zhao","year":"2020","unstructured":"Zhao G, Cheng D, Wang Y, Cao Y, Xiang S, Yu Q. A metabolomic study for chronic heart failure patients based on a dried blood spot mass spectrometry approach. RSC Adv. 2020;10(33):19621\u20138.","journal-title":"RSC Adv"},{"issue":"1","key":"4240_CR21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.18632\/aging.102670","volume":"12","author":"L Yu","year":"2020","unstructured":"Yu L, Li K, Li X, Guan C, Sun T, Zhang X. Metabolomic profiling of dried blood spots reveals gender-specific discriminant models for the diagnosis of small cell lung cancer. Aging. 2020;12(1):978\u201395.","journal-title":"Aging"},{"issue":"6 Suppl","key":"4240_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/art.1780180706","volume":"18","author":"WN Kelley","year":"1975","unstructured":"Kelley WN, Holmes EW, Van der Weyden MB. Current concepts on the regulation of purine biosynthesis de novo in man. Arthritis Rheum. 1975;18(6 Suppl):673\u201380.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4240_CR23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/acr.24013","volume":"72","author":"F Wang","year":"2020","unstructured":"Wang F, Sun L, Zong G, Gao X, Zhang H, Xiong Q, et al. Associations of amino acid and acylcarnitine profiles with incident hyperuricemia in middle-aged and older chinese individuals. Arthritis Care Res. 2020;72(9):1305\u201314.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"4240_CR24","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789\u201398.","journal-title":"Ann Rheum Dis"},{"key":"4240_CR25","first-page":"1389","volume":"9","author":"Q Wang","year":"2016","unstructured":"Wang Q, Sun T, Cao Y, Gao P, Dong J, Fang Y, et al. A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection. Onco Targets Ther. 2016;9:1389\u201398.","journal-title":"Onco Targets Ther"},{"key":"4240_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate\u2014a new and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc B"},{"issue":"2","key":"4240_CR27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BOR.0b013e3283438e13","volume":"23","author":"JA Singh","year":"2011","unstructured":"Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011;23(2):192\u2013202.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"4240_CR28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1297-319X(01)00342-6","volume":"69","author":"V Guggi","year":"2002","unstructured":"Guggi V, Calame L, Gerster JC. Contribution of digit joint aspiration to the diagnosis of rheumatic diseases. Joint Bone Spine. 2002;69(1):58\u201361.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"4240_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.39799","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth N, Choi HK, Terkeltaub R. Review: gout: a roadmap to approaches for improving global outcomes. Arthritis Rheumatol. 2017;69(1):22\u201334.","journal-title":"Arthritis Rheumatol"},{"key":"4240_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jcp.31.Suppl_12.205","volume":"12","author":"JT Scott","year":"1978","unstructured":"Scott JT. New knowledge of the pathogenesis of gout. J Clin Pathol Suppl (R Coll Pathol). 1978;12:205\u201313.","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"4240_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8\u201314.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4240_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12199-017-0609-8","volume":"22","author":"MH Mahbub","year":"2017","unstructured":"Mahbub MH, Yamaguchi N, Takahashi H, Hase R, Amano H, Kobayashi-Miura M, et al. Alteration in plasma free amino acid levels and its association with gout. Environ Health Prev Med. 2017;22(1):7.","journal-title":"Environ Health Prev Med"},{"issue":"11","key":"4240_CR33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00726-018-2627-2","volume":"50","author":"Y Luo","year":"2018","unstructured":"Luo Y, Wang L, Liu XY, Chen X, Song YX, Li XH, et al. Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia. Amino Acids. 2018;50(11):1539\u201348.","journal-title":"Amino Acids"},{"key":"4240_CR34","doi-asserted-by":"crossref","first-page":"1045697","DOI":"10.3389\/fchem.2023.1045697","volume":"11","author":"X Kong","year":"2023","unstructured":"Kong X, Liang H, An W, Bai S, Miao Y, Qiang J, et al. Rapid identification of early renal damage in asymptomatic hyperuricemia patients based on urine Raman spectroscopy and bioinformatics analysis. Front Chem. 2023;11:1045697.","journal-title":"Front Chem"},{"issue":"23\u201324","key":"4240_CR35","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.cca.2011.07.031","volume":"412","author":"Y Liu","year":"2011","unstructured":"Liu Y, Sun X, Di D, Quan J, Zhang J, Yang X. A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique. Clin Chim Acta. 2011;412(23\u201324):2132\u201340.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"4240_CR36","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.bbadis.2013.05.002","volume":"1832","author":"AC Dankers","year":"2013","unstructured":"Dankers AC, Mutsaers HA, Dijkman HB, van den Heuvel LP, Hoenderop JG, Sweep FC, et al. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). Biochim Biophys Acta. 2013;1832(10):1715\u201322.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4240_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0026-0495(73)90269-2","volume":"22","author":"P Felig","year":"1973","unstructured":"Felig P. The glucose-alanine cycle. Metabolism. 1973;22(2):179\u2013207.","journal-title":"Metabolism"},{"issue":"4","key":"4240_CR38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcb.22174","volume":"107","author":"J Pandhare","year":"2009","unstructured":"Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem. 2009;107(4):759\u201368.","journal-title":"J Cell Biochem"},{"key":"4240_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fphar.2014.00151","volume":"5","author":"V Ribas","year":"2014","unstructured":"Ribas V, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Glutathione and mitochondria. Front Pharmacol. 2014;5:151.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4240_CR40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.220635","volume":"50","author":"FK Alduraibi","year":"2023","unstructured":"Alduraibi FK, Saleem M, Ricart K, Patel RP, Szalai AJ, Singh JA. Clustering patients with gout based on comorbidities and biomarkers: a cross-sectional study. J Rheumatol. 2023;50(6):817\u201326.","journal-title":"J Rheumatol"},{"key":"4240_CR41","doi-asserted-by":"crossref","first-page":"109526","DOI":"10.1016\/j.abb.2023.109526","volume":"736","author":"FF Lopes","year":"2023","unstructured":"Lopes FF, Lamberty Faverzani J, Hammerschmidt T, Aguilar Delgado C, Ferreira de Oliveira J, Wajner M, et al. Evaluation of oxidative damage to biomolecules and inflammation in patients with urea cycle disorders. Arch Biochem Biophys. 2023;736:109526.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"4240_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-018-1600-5","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang H, Chang D, Guo F, Pan H, Yang Y. Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout. Arthritis Res Ther. 2018;20(1):111.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4240_CR43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2022.10.003","volume":"137","author":"H Iijima","year":"2022","unstructured":"Iijima H, Kubota M. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency. Mol Genet Metab. 2022;137(3):301\u20137.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4240_CR44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s003940050074","volume":"39","author":"JJ Boza","year":"2000","unstructured":"Boza JJ, Mo\u00ebnnoz D, Bournot CE, Blum S, Zbinden I, Finot PA, et al. Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells. Eur J Nutr. 2000;39(1):38\u201346.","journal-title":"Eur J Nutr"},{"issue":"2","key":"4240_CR45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.17219\/acem\/61609","volume":"26","author":"Y Xu","year":"2017","unstructured":"Xu Y, Jiang W, Chen G, Zhu W, Ding W, Ge Z, et al. L-carnitine treatment of insulin resistance: a systematic review and meta-analysis. Adv Clin Exp Med. 2017;26(2):333\u20138.","journal-title":"Adv Clin Exp Med"},{"key":"4240_CR46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clinbiochem.2021.10.002","volume":"98","author":"A Habib","year":"2021","unstructured":"Habib A, Azize NAA, Rahman SA, Yakob Y, Suberamaniam V, Nazri MIBA, et al. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia. Clin Biochem. 2021;98:48\u201353.","journal-title":"Clin Biochem"},{"key":"4240_CR47","volume":"158","author":"L You","year":"2022","unstructured":"You L, Zheng F, Su C, Wang L, Li X, Chen Q, et al. Metabolome-wide association study of serum exogenous chemical residues in a cohort with 5 major chronic diseases. Environ Int. 2022;158:106919.","journal-title":"Environ Int"},{"issue":"11","key":"4240_CR48","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62(11):3237\u201348.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4240_CR49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","volume":"25","author":"C Li","year":"2013","unstructured":"Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25(2):210\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"4240_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman MG, Vaz FM, Houten SM, Soeters MR. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 2013;62(1):1\u20138.","journal-title":"Diabetes"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-04240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:52:33Z","timestamp":1730303553000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-04240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4240"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-04240-3","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine. Written informed consent from all participants was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"769"}}